StockData
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. (BEAM) stock

BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3014% below fair value
$20.65−0.29 (-1.38%)

Close on Nov 17, 2026Market cap $2.13BP/E –Yield –

Beam Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Beam Therapeutics's market cap was $2.67B on Nov 11, 2026, against $2.57B a year earlier. Over the last 5 years it ranged from $1.59B to $5.40B, with a median of $2.52B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.67B-5.1%
2025Dec 31, 2025$2.81B+37.2%
2024Dec 31, 2024$2.05B-5.2%
2023Dec 29, 2023$2.16B-21.6%
2022Dec 30, 2022$2.76B-48.9%
2021Dec 31, 2021$5.40B+31.1%
2020Dec 31, 2020$4.12B–

More Beam Therapeutics figures

See a number that looks wrong?